Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brendon J Coventry

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Adjuvant immunotherapy of patients with high-risk melanoma using vaccinia viral lysates of melanoma: results of a randomized trialPeter Hersey, Alan S Coates, William H McCarthy, et al.
Journal of Surgical Oncology|March 18, 2014
Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanomaBrendon J Coventry, Hidde M Kroon, Mitchell H Giles, et al.
Molecular Pharmaceutics|October 29, 2013
Diamide linked γ-cyclodextrin dimers as molecular-scale delivery systems for the medicinal pigment curcumin to prostate cancer cellsTakaaki Harada, Lauren Giorgio, Tiffany J Harris, et al.
Annals of Surgical Oncology|October 29, 2014
Phase 2 Study of Intralesional PV-10 in Refractory Metastatic MelanomaJohn F Thompson, Sanjiv S Agarwala, B Mark Smithers, et al.
The Medical Journal of Australia|March 8, 2005
Achieving equal standards in medical student education: is a national exit examination the answer?Bogda Koczwara, Martin H N Tattersall, Michael B Barton, et al.
Annals of Surgical Oncology|November 20, 2015
Australian Multicenter Study of Isolated Limb Infusion for MelanomaHidde M Kroon, Brendon J Coventry, Mitchell H Giles, et al.
The Lancet. Oncology|May 12, 2012
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBryan H Burmeister, Michael A Henderson, Jill Ainslie, et al.
The Lancet. Oncology|July 25, 2015
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trialMichael A Henderson, Bryan H Burmeister, Jill Ainslie, et al.
Australian Journal of General Practice|June 21, 2019
Improving diagnostic accuracy for suspicious melanocytic skin lesions: New Australian melanoma clinical practice guidelines stress the importance of clinician/pathologist communicationRichard Scolyer, H Peter Soyer, John W Kelly, et al.
The New England Journal of Medicine|September 29, 2006
Sentinel-node biopsy or nodal observation in melanomaDonald L Morton, John F Thompson, Alistair J Cochran, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Adjuvant immunotherapy of patients with high-risk melanoma using vaccinia viral lysates of melanoma: results of a randomized trialPeter Hersey, Alan S Coates, William H McCarthy, et al.
Journal of Surgical Oncology|March 18, 2014
Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanomaBrendon J Coventry, Hidde M Kroon, Mitchell H Giles, et al.
Molecular Pharmaceutics|October 29, 2013
Diamide linked γ-cyclodextrin dimers as molecular-scale delivery systems for the medicinal pigment curcumin to prostate cancer cellsTakaaki Harada, Lauren Giorgio, Tiffany J Harris, et al.
Annals of Surgical Oncology|October 29, 2014
Phase 2 Study of Intralesional PV-10 in Refractory Metastatic MelanomaJohn F Thompson, Sanjiv S Agarwala, B Mark Smithers, et al.
The Medical Journal of Australia|March 8, 2005
Achieving equal standards in medical student education: is a national exit examination the answer?Bogda Koczwara, Martin H N Tattersall, Michael B Barton, et al.
Annals of Surgical Oncology|November 20, 2015
Australian Multicenter Study of Isolated Limb Infusion for MelanomaHidde M Kroon, Brendon J Coventry, Mitchell H Giles, et al.
The Lancet. Oncology|May 12, 2012
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBryan H Burmeister, Michael A Henderson, Jill Ainslie, et al.
The Lancet. Oncology|July 25, 2015
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trialMichael A Henderson, Bryan H Burmeister, Jill Ainslie, et al.
Australian Journal of General Practice|June 21, 2019
Improving diagnostic accuracy for suspicious melanocytic skin lesions: New Australian melanoma clinical practice guidelines stress the importance of clinician/pathologist communicationRichard Scolyer, H Peter Soyer, John W Kelly, et al.
The New England Journal of Medicine|September 29, 2006
Sentinel-node biopsy or nodal observation in melanomaDonald L Morton, John F Thompson, Alistair J Cochran, et al.
Pageof 5